Jefferson County to purchase old Arsenal Street fire station
County Administrator Ryan Piche said the purchase is contingent upon a phase-one environmental review of the property and a structural review of the building.
The building, located at 217 Arsenal St., is set to be purchased for $500,000 from the current owner, 217 Arsenal Street LLC, of Pittsford, Monroe County.
Piche said the immediate use is for parking, but added there are options available for the county for future development.
"We intend to use the building," he said in a text message.
Piche said there is a need for additional office and storage space.
"The county has desired to add this parcel to our downtown campus for quite some time," he said.
It was approved as a "late resolution" Wednesday night because the county did not have the seller's sign-off before the Finance and Rules Committee meeting last week, Piche said.
The building was previously owned by Timothy E. Kelly and D. Edward Grant until selling it in January 2003 to Tallmadge LLC., Lake Katrine.
Kelly operated Tallmadge Tire and Auto Service Center at the location from 1992 until his retirement in 2001. The building has since remained vacant.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
10 minutes ago
- Associated Press
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In PepGen To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in PepGen between March 7, 2024 and March 3, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, July 06, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against PepGen Inc. ('PepGen' or the 'Company') (NASDAQ: PEPG) and reminds investors of the August 11, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (i) PGN-EDO51 was less effective and safe than Defendants had led investors to believe; (ii) the CONNECT2 study was dangerous or otherwise deficient for purposes of U.S. Food and Drug Administration ('FDA') approval; (iii) as a result of all the foregoing, PepGen was likely to halt the CONNECT2 study, and PGN-EDO51's clinical, regulatory, and commercial prospects were overstated; and (iv) as a result, Defendants' public statements were materially false and misleading at all relevant times. On July 30, 2024, PepGen issued a press release announcing purported 'positive clinical data from the first dose cohort (5 mg/kg) of PGN-EDO51' in its ongoing CONNECT1 study. Among other results, the Company reported that 'PGN-EDO51 achieved a mean absolute dystrophin level of 0.61% of normal and a 0.26% change from baseline after 4 doses, measured at week 13 by Western blot analysis.' However, as subsequently noted by a Stifel analyst, 'the magnitude of dystrophin increase was below what [PepGen] anticipated, which is disappointing[.]' Likewise, a Leerink Partners analyst noted that the low dose missed PepGen's expectations of 1% or greater dystrophin expression. On this news, PepGen's stock price fell $5.55 per share, or 32.69%, to close at $11.43 per share on July 31, 2024. On December 16, 2024, PepGen issued a press release announcing that it had received a clinical hold notice from the FDA regarding an Investigational New Drug ('IND') application 'to initiate the [CONNECT2] clinical trial in patients with [DMD]' in the U.S. Notably, the FDA's issuance of a clinical hold notice for the IND application indicated that the FDA had concerns regarding risks posed to patients in the CONNECT2 study and/or there were other deficiencies associated with the study. On this news, PepGen's stock price fell $0.17 per share, or 3.63%, to close at $4.51 per share on December 16, 2024. On January 29, 2025, PepGen issued a press release providing updates regarding safety concerns observed in the CONNECT1 study and the FDA's concerns regarding the CONNECT2 study. With respect to the CONNECT1 study, the press release stated, inter alia, that '[d]osing of one of the[] . . . participants [in the 10 mg/kg cohort] was paused due to a reduction of his estimated glomerular filtration rate[.]' In addition, PepGen 'ha[d] received communication from Health Canada . . . request[ing] additional information from the Company to address Health Canada's safety concerns before any further dose escalation or enrollment of any additional participants at the current dose levels.' With respect to the CONNECT2 study, the same press release stated, in relevant part, that '[t]he Company is working with the FDA to address its questions regarding supportive data for the dosing levels planned for the patient population.' Following these disclosures, PepGen's stock price fell $0.40 per share, or 21.74%, to close at $1.44 per share on January 30, 2025. On March 4, 2025, PepGen issued a press release 'announc[ing] its voluntary decision to temporarily pause the [CONNECT2] study . . . until the Company can review results from the 10 mg/kg cohort in the ongoing [CONNECT1] study.' On this news, PepGen's stock price fell $0.53 per share, or 18.86%, to close at $2.28 per share on March 4, 2025. Then, on May 28, 2025, PepGen issued a press release announcing that 'PGN-EDO51 did not achieve target dystrophin levels' in the CONNECT1 study and had chosen to discontinue development of its DMD programs. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding PepGen's conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the PepGen class action, go to or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner. A photo accompanying this announcement is available at
The Hill
an hour ago
- The Hill
Democrats might be ‘overthinking' strategy to recapture voters
Democrats are rethinking ways to recapture voters they've lost to President Trump in recent election cycles, and they may have been offered an important lesson in the New York mayoral primary. In various post-mortems and focus groups done on the heels of their devastating 2024 election loss, Democrats have thoroughly examined exit polls and voter demographics in search of the gaps in their party's appeal. But Democratic strategist Chuck Rocha, who served as a senior adviser on Sen. Bernie Sanders's (I-Vt.) presidential campaign in 2020, said Democrats are 'overthinking' the solution by analyzing the voters who flipped sides or skipped voting during the last election. 'It's more simple than that,' Rocha said. 'Just concentrate on people who are frustrated as hell and get both of them.' Rocha pointed to the New York mayoral race as proof. He says progressive upstart-turned-party nominee Zohran Mamdani (D) was able to capture voters — including those who did not vote a few months ago in the presidential election — by talking about affordability and other tangible economic issues that appealed to them. Rocha said voters 'want anything that's different' from the status quo when it comes to the cost of living. 'It shows how desperate people are,' he said. While many Democrats disagree with Mamdani's politics, they say the campaign he ran shows the unwavering preeminence of economic issues. And Trump taught the same lesson in 2024, political observers say, by telling voters what they wanted to hear on the economy and his message on 'draining the swamp.' 'Donald Trump and Zohran Mamdani just showed, in very different elections, that economic issues are still king — and that you can appeal to a wide, bipartisan swath of voters by saying you'll bring down the cost of living,' said Democratic strategist Christy Setzer. 'Working-class voters have been drifting away from the Democratic Party on so-called 'cultural' issues for a long time, but they're still very gettable through a clear message and from a compelling messenger.' According to exit polls, Democrats in 2024 lost significant ground with middle-class voters, a cornerstone of their traditional base, down 10 percentage points from 2020. At the same time, there is a decreasing sense of strong party leadership and little optimism about the party's future, respective CNN/SSRS and AP/NORC polling out in May revealed. But Mamdani, a self-proclaimed democratic socialist, took aim at the Democratic establishment, calling for draining the swamp to make room for change. It was an echo of Trump's messaging in his 2024 campaign. 'Donald Trump was successful because … he wasn't afraid to be against and call out people in his own party and other parties,' said Susan Del Percio, a longtime New York-based Republican strategist who does not support Trump. 'Mamdani was the exact same. He was calling out everybody, and then that's when you get to act with no fear.' Mamandi strayed from the Democratic establishment with a clear message of affordability and came out on top in a crowded and competitive primary. Former New York Gov. Andrew Cuomo, Mamdani's only serious competition, ran on a message of protecting New York City from Trump. But the New York City electorate is drastically different from the rest of the country, political observers say, noting someone like Mamdani may not appeal to moderates and centrists. 'Being a self-proclaimed democratic socialist … doesn't play in swing districts. It plays in New York City primaries,' Del Percio said. 'The Democratic candidates have to look more like Elissa Slotkin talking about the cost of living than they do Mamdani talking about the cost of living.' Realizing they need to do more to appeal to the middle class, Democrats across the country have begun to put forward plans and back legislation to regain lost ground. Sen. Elissa Slotkin (D-Mich.) recently came out with her 'Economic War Plan,' the goals of which, she has said, are to reconnect the Democratic Party with the middle class. At the same time, Gov. Gavin Newsom (D-Calif.) signed a bill this week overhauling California's environmental protection laws to accelerate much-needed housing construction in the state. In the name of bringing down the cost of living, Newsom's move goes against a history of California Democrats unconditionally defending the state's environmental protection laws. But the New York race gave some Democrats an injection of hope that their party was starting to turn things around after the crushing loss last year. 'We have proof now, and the proof is the NYC mayor's race,' Rocha said. Mamdani won 'the same precincts in New York City where Donald Trump overperformed in the general election,' he explained. Democratic strategist Jamal Simmons said while not every voter is gettable, 'a lot of them are,' and he said some of the people who supported Trump are Democrats who simply found Trump's message more compelling than the Democratic ticket in the 2024 race. 'Voters are not captive to any political party,' Simmons added. 'They have agency. They get to make their own choices, and if politicians aren't speaking to them, they'll look elsewhere.'
Forbes
an hour ago
- Forbes
How These French Founders Built A Warby Parker Competitor That's Even More Affordable
T he three founders of Izipizi, a French eyewear company founded in 2010, are staring at a decades-old photo of themselves on an iPad in an office in New York. Now in their late 30s, Xavier Aguera, Charles Brun and Quentin Couturier are 17 in the image, taken six years before the lifelong friends launched the brand that now brings in nearly $60 million in annual revenue. 'We had no links to the eyewear industry,' says Aguera, rolling back the years. 'We had a common will to create a company one day, and a curiosity and capacity to listen to customers.' Adds Couturier, 'There were no sexy brands for people, and we decided to create a cool one.' Founded in Paris in 2010 as See Concept, the affordable luxury brand—also known as masstige—was launched a few months after and an ocean away from Warby Parker, but the companies have distinctly different visions. Both sell premium readers, sunglasses and blue-light glasses for less (Izipizi's prices range from about $50 to $75, while Warby Parker starts at $95 and goes up) to chic customers who don't want to spend a fortune to see and be seen. But Warby Parker famously launched with a direct-to-consumer strategy, while See Concept opted for a brick-and-mortar approach. Both brands understood their customer—American consumers wanted the convenience of trying on glasses at home, while the French valued the in-store experience. Warby Parker has obviously been more successful of the two—its revenue last year was $770 million—but the brand has never expanded beyond the United States and Canada. Izipizi saw itself more in the mold of Swatch, the inexpensive Swiss watch company founded in the early 1980s, that is now ubiquitous and includes such luxury brands as Omega, Breguet and Blancpain. But that was not the dream when the three friends met as teenagers in Lyon, France, bonding over sports, partying and skiing on weekends. After graduating, they each went to business school in Paris and all left wanting to be entrepreneurs. They reunited at 23 to start a business initially offering self-service reading glasses in places like banks and hotels—similar to a communal pen attached to a chain at a post office. 'I had the idea at the beginning because my mom was always looking for her glasses in restaurants and banks,' says Couturier, who oversees sales in European, Asian and South American markets. 'She would say 'Could you help me to read? Give me your eyes.' Our tag line was 'Clear vision at your fingertips.'' They each invested around $6,500 each to get the business off the ground, and Aguera and Brun had also just won a prize from their business school which gave them access to bank loans. They borrowed an additional $260,000 in loans to launch and earned slightly more than that in sales in their first year. They doubled their revenue in 2011 and then grew again, to around $850,000 in sales, in 2012. Despite the consistent growth, it was not the success the trio had hoped it would be. 'We thought we could sell these all around the world to millions of places,' recalls Brun, who focuses on the company's sales in North America. 'The product was useful, but it was hard for people to understand the need and to convince places like banks and post offices.' The first two years in the eyewear business showed trio that there was also untapped potential in the more traditional market of reading glasses. So they pivoted in an effort to 'reinvent reading glasses from conventional products to a sexy lifestyle and fashion product,' says Brun. Clear Vision: 'As soon as we had the real reading glasses, we saw it was a success within a few days. We had to order quickly and said, 'Now let's sell it all over the world.'" Izipizi They raised nearly $800,000 between two fundraising rounds in 2012 and 2013 from friends and family to support the new vision, which initially gave a minority equity share to two lead investors. Now working with a manufacturing company in Taiwan, they began selling their new glasses at trade shows to meet buyers and retailers from around the world. Their big break came when they launched in the luxury Parisian boutique Colette. See Concept earned just under $4 million in revenue in 2013, also making a net profit for the first time. From then, the founders understood how to scale the brand. They started launching the product across Europe's most fashionable department stores and neighborhoods. 'Since the first day when we launched in Collette, Le Bon Marché, Selfridges and Harrods, it was a big surprise for customers,' Couturier says. 'They were very rich people who loved luxury brands and the good things.' 'We had French actors and celebrities saying, 'Oh, I bought this at Colette for 30 euros.',' Brun adds. 'As soon as we had the real reading glasses, we saw it was a success within a few days. We had to order quickly and said, 'Now let's sell it all over the world.' But our aim was to make sure we sold to the best stores all over the world.' The following year, the company expanded their product line into sunglasses, and soon added kids' and sports eyewear. See Concept was still growing fast and the founders made another big decision—to rebrand with a new, memorable name that's a play on 'easy peasy.' They also launched a flagship store in Paris in September 2017. 'It's a great name, Izipizi,' says Aguera, who heads the brand's global marketing and brand strategy. 'It's a palindrome, which means you can read it from both sides. And when you say it out loud, you must say it with a smile.' Izipizi continued to steadily increase its retail footprint until 2020, when the Covid pandemic forced shoppers to go online. They may not have wanted to go down the Warby Parker path, but lockdown changed the rules. 'At first we were really ashamed to sell online because our customers were complaining,' Brun remembers. 'We really had the boom on our website during Covid.' Cool Britannia: King Charles III wearing Izipizi sunglasses on a 2024 trip to Samoa. Victoria Jones-Pool/Getty Images Today, about 30% of Izipizi's sales come from e-commerce purchases. The largest portion of its revenue comes from stores in France, the U.S., and other parts of Europe including the U.K., Germany and Italy. Izipizi has leaned into collaborations with companies and stores, including Moleskine, the Museum of Modern Art and Parisian boutique Merci. The brand now has 20 of its own retail locations and is sold in 7,500 other retailers across 85 countries. Or, as Couturier says, 'Izipizi is everywhere you need glasses.' In 2022, Aguera, Brun and Couturier bought out their minority shareholders and brought in New York-based private equity firm TowerBrook Capital Partners, which injected Izipizi with an estimated $45 million in capital for 25% of the company. The three founders now collectively own the other 75% divided equally. Last year, Izipizi hired Jonathan Crespo, who previously had a senior role at Oliver Peoples, the Los Angeles-based eyewear brand launched in the 1980s, as its first North America CEO. Since then, the founders have been eyeing a big expansion in the United States. Izipizi is already in department stores such as Bloomingdale's but is looking to launch its first American retail location in 2026. Back in New York City, Aguera, Brun and Couturier, who have virtually only ever had one job in their entire lives with one another, have to leave to take a meeting with Bloomingdale's. A few blocks downtown, a woman hurriedly throws open the passenger side door of a car, almost causing her Izipizi sunglasses case to fall out. More from Forbes Forbes How Crumbl Devoured America By Simone Melvin Forbes Patrick Schwarzenegger's Next Big Flex By Simone Melvin Forbes Teens And Tweens Are Obsessed With This Skincare Brand For Babies—Now It Brings In $100 Million A Year By Simone Melvin
